| Literature DB >> 30514325 |
C M den Bakker1,2, F G Schaafsma3, J A F Huirne4, E C J Consten5, H B A C Stockmann6, C J Rodenburg7, G J de Klerk8, H J Bonjer9, J R Anema3.
Abstract
BACKGROUND: More colon cancer patients are expected to fully recover after treatment due to earlier detection of cancer and improvements in general health- and cancer care. The objective of this study was to gather participants' experiences with full recovery in the different treatment phases of multimodal treatment and to identify their needs during these phases. The second aim was to propose and evaluate possible solutions for unmet needs by the introduction of eHealth.Entities:
Keywords: Cancer care. eHealth; Colon cancer; Multimodal treatment; Patient reported outcomes; Recovery
Mesh:
Year: 2018 PMID: 30514325 PMCID: PMC6278104 DOI: 10.1186/s12885-018-5105-z
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Baseline characteristics
| Study number | Gender | Age at operation (ranges in years) | Comorbiditiy | Operation | Postoperative complications | Age at focus group (years) | Time after operation (months) | Time after last course of CTx (months) | 8 courses of CTx received | Stoma |
|---|---|---|---|---|---|---|---|---|---|---|
| FG1-R1 | Male | 65–70 | Yes | Laparascopic | No | 65–70 | 10 | 5 | No | No |
| FG1-R2 | Female | 40–45 | No | Open procedure | No | 40–45 | 14 | 6 | Yes, with adjusted dose | Yes |
| FG1-R3 | Male | NA | No | Conversion to open | Yes | 75–80 | NA | 4 | Yes, with adjusted dose | No |
| FG1-R4 | Female | 60–65 | Yes | Laparascopic | No | 60–65 | 17 | 11 | Yes, with adjusted dose | No |
| FG1-R5 | Female | 60–65 | Yes | Laparascopic | No | 60–65 | 17 | 10 | Yes, with adjusted dose | No |
| FG1-R6 | Male | NA | No | Laparascopic | No | 70–75 | NA | 11 | Yes, with adjusted dose | No |
| FG1-R7 | Male | 65–70 | Yes | Laparascopic | No | 65–70 | 16 | 11 | No | Yes |
| FG1-R8 | Male | 60–65 | No | Laparascopic | No | 60–65 | 16 | 12 | Yes, with adjusted dose | No |
| FG1-R9 | Male | 70–75 | Yes | Open procedure | Yes | 70–75 | 12 | 4 | Yes, with adjusted dose | No |
| FG1-R10 | Male | 60–65 | Yes | Laparascopic | No | 60–65 | 11 | 4 | Yes | No |
| FG1-R11 | Female | 30–35 | No | Conversion to open | Yes | 30–35 | 22 | 15 | Yes, with adjusted dose | No |
| FG2-R1 | Female | 75–80 | Yes | Laparascopic | No | 75–80 | 8 | 2 | Yes | No |
| FG2-R2 | Female | 50–55 | Yes | Laparascopic | No | 55–60 | 14 | 10 | No | No |
| FG2-R3 | Male | 65–70 | No | Laparascopic | Yes | 65–70 | 16 | 9 | Yes | No |
| FG2-R4 | Male | 50–55 | Yes | Laparascopic | No | 50–55 | 14 | 8 | Yes, with adjusted dose | No |
| FG2-R5 | Male | 55–60 | Yes | Open procedure | No | 55–60 | 11 | 4 | No | Yes |
| FG2-R6 | Female | 55–60 | No | Laparascopic | No | 55–60 | 12 | 6 | Yes, with adjusted dose | No |
| FG2-R7 | Female | 65–70 | Yes | Laparascopic | No | 65–70 | 20 | 12 | No | No |
| FG2-R8 | Female | 65–70 | Yes | Laparascopic | No | 65–70 | 22 | 15 | Yes, with adjusted dose | No |
| FG2-R9 | Male | 60–65 | Yes | Laparascopic | No | 65–60 | 20 | 17 | No | No |
| FG2-R10 | Female | 55–60 | No | Laparascopic | No | 55–60 | 15 | 9 | Yes, with adjusted dose | No |
| FG2-R11 | Female | 70–75 | No | Open procedure | Yes | 70–75 | 15 | 8 | Yes | Yes |
FG1 Focus group discussion 1, FG2 Focus group discussion 2, R Respondent number
Fig. 1Proposed recovery paths according to patients after multimodal treatment for colon cancer including all needs per treatment phase. Met needs are presented in green, unmet needs in red. CTx = Chemotherapy
All mentioned unmet needs including possible solutions by eHealth & ICT according to the participants
Provided solutions are presented in green, in case no solution was mentioned these answers are presented in red